EZH2
protein-codingenhancer of zeste 2 polycomb repressive complex 2 subunit, the group of Polycomb repressive complex 2|Lysine methyltransferases|Myb/SANT domain containing|SET domain containing
Gene summary
This gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Multiple alternatively splcied transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Feb 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~77.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0010193
Submitter: ClinGen
*EZH2* was first reported in relation to autosomal dominant Weaver syndrome in 2011 (PMID: 22190405). Weaver syndrome (WS) is a rare multisystem disorder characterized by tall stature, a typical facial appearance, and variable intellectual disability. Additional features may include camptodactyly, advanced bone age, soft doughy skin, umbilical hernia, and a low hoarse cry (PMIDs: 22190405, 23865096, 24214728). *EZH2* variants have also been observed in individuals with overgrowth who did not have a clinical diagnosis of Weaver syndrome (PMIDs: 22190405, 24214728). *EZH2* variants, primarily missense, as well as a small number of nonsense, frameshift, and in-frame insertion or deletion variants, have been identified in over 50 individuals with Weaver syndrome or overgrowth (PMIDs: 22177091, 22190405, 24214728, 32243864). Truncating variants are uncommon and to date have only been identified in the last or penultimate exon (PMID: 24214728, ClinVar variation ID: 207471). Only 11 probands are included in this curation because the maximum score for genetic evidence has been reached. *EZH2* encodes a histone methyltransferase. Pathogenic variants in EZH2 generate a highly specific DNA methylation signature (PMID: 32243864). The disease mechanism is loss of function (PMIDs: 26694085, 29244146, 32243864). However, the fact that truncating variants have only been reported in the last or penultimate exon and may therefore escape nonsense-mediated decay suggests that they may not act through haploinsufficiency (PMID: 22190405, 24214728). This gene-disease relationship is also supported by experimental evidence, including protein interaction, functional alterations, and mouse model studies (PMIDs: 15225548, 26694085, 29244146, 32243864). In summary, there is definitive evidence supporting the relationship between *EZH2* and Weaver syndrome. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 3, 2022 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0010193
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0010193
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0010193
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0010193
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to EZH2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004456.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 141 | 2 | 150 | ||
| missense | 6 | 33 | 216 | 29 | 5 | 289 |
| nonsense | 1 | 2 | 8 | 11 | ||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 2 | 14 | 17 | ||
| splice donor/acceptor (+/-2bp) | 7 | 7 | ||||
| Total | 8 | 37 | 253 | 170 | 7 | 475 |
Highest pathogenic variant AF is 0.0000065717704
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004447.2 | 19 | MANE Select | |
| Ensembl | ENSP00000320147.2 | 19 | MANE Select | |
| RefSeq | NP_001190176.1 | 19 | Standard | |
| RefSeq | NP_001190177.1 | 19 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ezh2 | Danio rerio | Structure: cardiac muscle cell Quality: detached from abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysine degradation - Homo sapiens (human)
- MicroRNAs in cancer - Homo sapiens (human)
- miR-targeted genes in epithelium - TarBase
- miR-targeted genes in lymphocytes - TarBase
- miR-targeted genes in muscle cell - TarBase
Biological Process
- negative regulation of transcription by RNA polymerase II
- DNA methylation
- chromatin organization
- regulation of transcription, DNA-templated
- positive regulation of cell population proliferation
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- RNA polymerase II core promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- chromatin binding
Cellular Component
- nuclear chromatin
- nucleus
- nucleoplasm
- cytoplasm
- ESC/E(Z) complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000320356
- Coding exons
- 19
- Length
- 76939
- Individuals with no LoFs
- 109672
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 109674
- p
- 0.00000912
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.68 | 154 | 426 | 0.362 | 0.0000236 | 5005 |
| Missense (PolyPhen) | 29 | 145.5 | 0.19932 | 1811 | ||
| Synonymous | -1.18 | 163 | 145 | 1.12 | 0.00000796 | 1335 |
| Loss of Function | 5.81 | 2 | 43.2 | 0.0463 | 0.00000226 | 524 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000081 | 0.000040 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00012 | 0.000062 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys- 27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2 (PubMed:22323599). Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A and retinoic acid target genes. EZH2 can also methylate non- histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA. Regulates the circadian clock via histone methylation at the promoter of the circadian genes. Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK-ARNTL/BMAL1 heterodimer; involved in the di and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters which is necessary for the CRY1/2 proteins to inhibit transcription. {ECO:0000269|PubMed:14532106, ECO:0000269|PubMed:15225548, ECO:0000269|PubMed:15231737, ECO:0000269|PubMed:15385962, ECO:0000269|PubMed:16179254, ECO:0000269|PubMed:16357870, ECO:0000269|PubMed:16618801, ECO:0000269|PubMed:16717091, ECO:0000269|PubMed:16936726, ECO:0000269|PubMed:17210787, ECO:0000269|PubMed:17344414, ECO:0000269|PubMed:18285464, ECO:0000269|PubMed:19026781, ECO:0000269|PubMed:20935635, ECO:0000269|PubMed:22323599, ECO:0000269|PubMed:23063525, ECO:0000269|PubMed:24474760}.;
- Disease
- DISEASE: Weaver syndrome (WVS) [MIM:277590]: A syndrome of accelerated growth and osseous maturation, unusual craniofacial appearance, hoarse and low-pitched cry, and hypertonia with camptodactyly. Distinguishing features of Weaver syndrome include broad forehead and face, ocular hypertelorism, prominent wide philtrum, micrognathia, deep horizontal chin groove, and deep-set nails. In addition, carpal bone development is advanced over the rest of the hand. {ECO:0000269|PubMed:22177091, ECO:0000269|PubMed:22190405, ECO:0000269|PubMed:23239504, ECO:0000269|PubMed:26694085, ECO:0000269|PubMed:28229514}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.315
Intolerance Scores
- LoFtool
- 0.0135
- RVIS EVS
- -0.54
- RVIS percentile EVS
- 20.54
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.966
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |